For centuries, Thailand has produced premium silk fabrics. Now, researchers in Bangkok have found another use for the fiber: ...

The Australian facial injectables industry was estimated to be worth $4.1 billion in 2023, with big corporates including ...

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...

The clinical trial, led by scientists from King’s College London and sponsored by the University of Oxford, with support from drug firm AstraZeneca UK, was conducted at Oxford University Hospitals NHS ...

Study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab - administered as an ...

People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themsel ...

Scientists examine the effectiveness of an antibody targeting cell adhesion molecule 1 in alleviating pain-induced neuronal ...

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring HIV. This makes Lenacapavir significantly more ...

A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%.

From less vaccinations to physician burn-out, doctors fear the worst under Trump and Kennedy's vision for health ...

The ABC7 Chicago I-Team and ABC News are investigating the risks, and finding out how people are safely getting lower-cost ...